Search results
In Praise of First-Past-the-Post | by Andrés Velasco - Project Syndicate
Project Syndicate· 5 hours agoAndrés Velasco explains why Britain’s electoral system is better than all the plausible...
Editor’s Note | Learning About Mississippi, Deepening My Roots
Mississippi Free Press· 3 hours agoBecause I had this expectation, I did not think of Mississippi as “home.” Luckily, an opening at the...
Russian ransomware gangs account for 69% of all ransom proceeds
BleepingComputer· 6 hours agoRussian-speaking threat actors accounted for at least 69% of all crypto proceeds linked to...
Report: Man United Want Ambitious Defensive Swap Deal with Inter Milan
EPL Index via Yahoo Canada Sports· 9 hours agoManchester United’s Strategic Move: Eyeing Denzel Dumfries in a Potential Swap DealExploring the...
Mexican cartel leader known as "El Mayo" pleads not guilty in federal court
LA Times via Yahoo Canada News· 20 hours agoIsmael 'El Mayo' Zambada and Joaquín Guzmán López, two of Mexico's most-wanted men, were arrested at...
Five Overlooked Modernists From The Global South in Venice
Artnet News· 3 hours agoThe Venice Biennale’s first-ever Latin American curator, Adriano Pedrosa, chose the theme of...
KCK Democrat broke with party on trans rights, food assistance. Will it cost him his seat?
Kansas City Star via Yahoo Canada News· 9 hours agoRep. Marvin Robinson II, a first-term state lawmaker, faces a tough primary bid in his solidly...
Report: Aston Villa Pushing to Sign £35m Borussia Dortmund Star
EPL Index via Yahoo Canada Sports· 11 hours agoAston Villa’s Interest in Karim Adeyemi: A Smart Move?Aston Villa’s interest in Borussia Dortmund’s...
In Japan, Turning the Tables on Rude Customers
New York Times· 16 hours agoThe reporters visited a traditional Japanese inn in Nasushiobara, in Tochigi Prefecture, and reported from Tokyo. The guests arrived 30 minutes before...
ProMIS Neurosciences Reports Positive Top-Line Data from its Phase 1a Alzheimer's Trial
Digital Journal· 7 hours agoProMIS Neurosciences, Inc. (Nasdaq: PMN), a biotechnology company focused on the generation and development of antibody therapeutics targeting toxic misfolded proteins in neurodegenerative diseases ...